Accelera Innovations Financials

ACNV Stock  USD 0.0001  0.00  0.00%   
We suggest to use Accelera Innovations fundamental analysis to find out if markets are presently mispricing the company. Put another way you can use it to find out if Accelera Innovations is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We were able to interpolate twenty-five available fundamental indicators for Accelera Innovations, which can be compared to its peers. The stock experiences a normal downward fluctuation but is a risky buy. Check odds of Accelera Innovations to be traded at $1.0E-4 in 90 days.
  
Understanding current and past Accelera Innovations Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Accelera Innovations' financial statements are interrelated, with each one affecting the others. For example, an increase in Accelera Innovations' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Accelera Innovations' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Accelera Innovations. Check Accelera Innovations' Beneish M Score to see the likelihood of Accelera Innovations' management manipulating its earnings.

Accelera Innovations Stock Summary

Accelera Innovations competes with GE HealthCare, Veeva Systems, Solventum Corp, Doximity, and HealthEquity. Accelera Innovations, Inc., a healthcare service company, focuses on the development of Internet-based software in the United States. Accelera Innovations, Inc. was founded in 2008 and is based in Colorado Springs, Colorado. Accelera Innovations is traded on OTC Exchange in the United States.
InstrumentUSA Pink Sheet View All
ExchangePINK Exchange
Business Address60 Thurber Drive,
SectorHealthcare
IndustryHealth Information Services
BenchmarkDow Jones Industrial
Websitewww.accelerainnovations.com
Phone866 920 0758
CurrencyUSD - US Dollar

Accelera Innovations Key Financial Ratios

There are many critical financial ratios that Accelera Innovations' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Accelera Innovations reports annually and quarterly.

Accelera Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Accelera Innovations's current stock value. Our valuation model uses many indicators to compare Accelera Innovations value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Accelera Innovations competition to find correlations between indicators driving Accelera Innovations's intrinsic value. More Info.
Accelera Innovations is number one stock in return on asset category among its peers. It also is number one stock in operating margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Accelera Innovations' earnings, one of the primary drivers of an investment's value.

Accelera Innovations Systematic Risk

Accelera Innovations' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Accelera Innovations volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Accelera Innovations correlated with the market. If Beta is less than 0 Accelera Innovations generally moves in the opposite direction as compared to the market. If Accelera Innovations Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Accelera Innovations is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Accelera Innovations is generally in the same direction as the market. If Beta > 1 Accelera Innovations moves generally in the same direction as, but more than the movement of the benchmark.

Additional Tools for Accelera Pink Sheet Analysis

When running Accelera Innovations' price analysis, check to measure Accelera Innovations' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Accelera Innovations is operating at the current time. Most of Accelera Innovations' value examination focuses on studying past and present price action to predict the probability of Accelera Innovations' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Accelera Innovations' price. Additionally, you may evaluate how the addition of Accelera Innovations to your portfolios can decrease your overall portfolio volatility.